Business Development for the Biotech Community
line

Tukan Partners Ltd was established in 2005 as a business development consultancy, primarily for the biotech community.

The company has clients across Europe, the US and Asia and offers commercial, hands-on, transactional expertise to companies looking to add significant business development capabilities, on a part-time basis, to their growing organisations.

Tukan Partners has a successful track record in dealing with small-molecule, biologicals, generics medication and medical device companies, as well as university spin-outs, angel investments and venture-capital backed enterprises.

Typically, clients are seeking support to secure services, R&D collaborations, licensing and M&A arrangements.

line
LATEST NEWS: NodThera secures $40 million Series A financing................Microbiotica in $534 million Microbiome Deal with Genentech..............Microbiotica Collaborates with University of Adelaide...............Scrip Awards - Licensing Deal of the year 2017...........Microbiotica raises £8M and spins out of Wellcome Trust Sanger Institute...........Crescendo sign $790m collaboration with Takeda..........Chronos: Collaboration signed with large pharma………Abcodia worldwide, exclusive licence granted to ROCA...............